Erica Torchiaro

Candiolo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer.

Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer.

Journal: Journal of translational medicine

Published: June 06, 2024

Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification.

Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: November 30, 2023

Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient.

Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient.

Journal: Frontiers in oncology

Published: December 23, 2022

Corrigendum to 'COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC)': [ESMO Open Volume 6, Issue 3, June 2021, 100165].

Corrigendum to 'COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC)': [ESMO Open Volume 6, Issue 3, June 2021, 100165].

Journal: ESMO open

Published: August 05, 2021

COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC).

COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC).

Journal: ESMO open

Published: March 25, 2021

Patient-derived xenografts (PDXs) as model systems for human cancer.

Patient-derived xenografts (PDXs) as model systems for human cancer.

Journal: Current opinion in biotechnology

Published: January 01, 2020

Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions.

Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions.

Journal: EMBO molecular medicine

Published: January 20, 2017

The integrin-linked kinase-associated phosphatase (ILKAP) is a regulatory hub of ovarian cancer cell susceptibility to platinum drugs.

The integrin-linked kinase-associated phosphatase (ILKAP) is a regulatory hub of ovarian cancer cell susceptibility to platinum drugs.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 27, 2015

Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism.

Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism.

Journal: Oncotarget

Published: June 29, 2015

The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models.

The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 26, 2013

HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor.

HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor.

Journal: International journal of cancer

Published: February 12, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026